BioRegenx Reports Director/Officer Changes & Compensation

Ticker: BRGX · Form: 8-K · Filed: Jul 23, 2024 · CIK: 1593184

Bioregenx, INC. 8-K Filing Summary
FieldDetail
CompanyBioregenx, INC. (BRGX)
Form Type8-K
Filed DateJul 23, 2024
Risk Levelmedium
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: management-change, corporate-governance

TL;DR

BioRegenx is shuffling its board and execs, expect news on compensation soon.

AI Summary

BioRegenx, Inc. filed an 8-K on July 23, 2024, reporting events as of July 17, 2024. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. The company, formerly known as FindIt, Inc. and Artemis Energy Holdings, Inc., is incorporated in Nevada and headquartered in Chattanooga, Tennessee.

Why It Matters

Changes in a company's board of directors and executive officers, along with details on their compensation, can signal shifts in strategy or governance that may impact shareholders.

Risk Assessment

Risk Level: medium — Changes in key leadership and compensation structures can introduce uncertainty and potential shifts in company direction.

Key Players & Entities

FAQ

What specific changes occurred regarding directors or officers?

The filing indicates events related to the departure of directors or certain officers, the election of directors, and the appointment of certain officers.

When were these events reported to have occurred?

The earliest event reported in this 8-K filing was on July 17, 2024.

What is BioRegenx, Inc.'s state of incorporation?

BioRegenx, Inc. is incorporated in Nevada.

What is the company's principal executive office address?

The principal executive offices are located at 7407 Ziegler Road, Chattanooga, Tennessee 37421.

Has BioRegenx, Inc. operated under different names previously?

Yes, the company was formerly known as FindIt, Inc. and Artemis Energy Holdings, Inc.

Filing Stats: 358 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2024-07-22 19:01:37

Filing Documents

02 Departure of Directors or Certain Officers; Election of

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective July 17, 2024, Sherri Adams resigned as an officer and director of the Company to pursue other business interests. Her departure was not a result of any disagreement with the Company, its Board or management.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BioRegenx, Inc. (Registrant) Date: July 22, 2024 By: /s/ William Resides Name: William Resides Title: Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing